前臨床イメージングの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

前臨床イメージング市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の前臨床イメージング市場規模は2030年までに59億5,000万米ドルに達すると予測されています。

同市場は2023年から2030年にかけてCAGR 4.74％で成長すると予測されています。研究開発への多額の投資は、世界中の研究プロジェクトを後押ししています。その結果、前臨床イメージングの需要は着実に増加しています。医薬品、バイオテクノロジー、ライフサイエンス、医療機器、化粧品などは、研究開発においてイメージングモダリティが広く使用されている応用分野です。さらに、動物病院や教育機関もこの市場に新たな需要を生み出しています。

核医学技術（主に陽電子放射断層撮影法（PET）と単一光子放射コンピュータ断層撮影法（SPECT））、光学イメージング、マイクロコンピュータ断層撮影法（CT）、マイクロ磁気共鳴画像法（MRI）、光音響トモグラフィ（PAT）、超音波は、小動物の生体内イメージング用途に最も適したモダリティです。各モダリティにはそれぞれ利点と欠点があります。研究対象の病態生理学的プロセスに関する補完的な情報を提供するために設計されたマルチモダリティ装置は、各イメージングモダリティ固有の限界を克服することを目指し、急速に普及しています。micro-CTやmicro-MRIのような高分解能モダリティと、micro-PETやmicro-SPECTのような機能的情報を提供する高感度技術との組み合わせは、感染症、腫瘍、循環器、神経などの主要分野における研究の視野を広げ、疾患の基礎メカニズムの理解に貢献するだけでなく、効率的かつ統一的な手段を提供することが期待されます。

新薬や新薬候補を評価するための効率的で統一されたツールを提供し、世界市場の成長を後押ししています。

世界市場の主要な競合企業は、新製品の上市や製造能力の強化など、製品ポートフォリオの充実を図るためにさまざまな取り組みを行っています。例えば、2023年2月に開催された第75回インド放射線画像学会（Indian Radiological and Imaging Association）において、FUJIFILM Indiaは機器とサービスの開発を発表しました。同社は2023年2月2日から5日までアムリトサルで開催されたイベントで、最先端の診断ツールを実演しました。最近発売されたMRI装置APERTO Lucent Non DICOMプリンターAPEOS、超音波診断装置Arietta 650 DeepInsightおよびArietta 850 DeepInsightは、すべて新しいポートフォリオの構成要素です。また、スマートフォン用アプリケーション「FUJIFILM Connect」もリリースされました。

さらに、がん研究・調査のアプリケーションで使用される高スループット超音波イメージングシステムの進歩が市場を押し上げます。2022年4月、パーキンエルマーはライブ画像解析の拡大を発表したが、その一環として、がん、腎臓・肝臓病、心臓病などの分野における非侵襲的臨床研究や創薬のスピードアップを可能にする、完全自動化技術とハイスループット能力を備えたハンドヘルド超音波イメージングシステム「Vega（ベガ）」を発売しました。非侵襲的イメージング法は、動物の不快感を最小限に抑えつつ、侵襲的手術の必要性を低減するため、その使用が奨励されています。前臨床イメージング技術は、このような倫理的配慮の結果として採用されています。

前臨床イメージング市場レポートハイライト

• 製品別では、光学イメージングセグメントが、小動物イメージングや新薬発見プロジェクトでの幅広い使用により、2022年に13.6%の最大収益シェアを占めました。
• 用途別では、技術進歩やヘルスケアインフラの改善により、研究開発分野が2022年に54.93%の最大売上シェアを占めました。
• 最終用途別では、製薬・バイオ企業分野が2022年に40.19%と最大の収益シェアを占めました。製薬・バイオ企業における絶え間ない研究活動と製品の革新が、市場プレイヤーの製品販売増につながり、市場成長を牽引しています。
• 地域別では、北米が2022年に最大の収益シェアを占めました。これは、研究インフラが発達していること、前臨床プロジェクトが多いこと、技術的に先進的なデバイスの採用率が高いことなどが要因です。
• 業界の主要企業は、人工知能対応システムなどの先進技術や機能の投入に注力しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 前臨床イメージング市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 前臨床イメージング市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 前臨床イメージング市場：製品別推定・動向分析

• 定義と範囲
• 製品市場シェア、2018年と2030年
• セグメントダッシュボード
• 製品別の前臨床イメージング市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 前臨床イメージング市場：用途別推定・動向分析

• 定義と範囲
• 用途市場シェア、2018年および2030年
• セグメントダッシュボード
• 用途別の前臨床イメージング市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第6章 前臨床イメージング市場：最終用途別推定・動向分析

• 定義と範囲
• 最終用途市場シェア、2018年および2030年
• セグメントダッシュボード
• 最終用途別の前臨床イメージング市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第7章 前臨床イメージング市場：地域別推定・動向分析

• 地域市場シェア分析、2020年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2020年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• SWOT分析、要因別（政治・法律、経済・技術）
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、量および動向分析、2018年から2030年：
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • 主なディストリビューターとチャネルパートナーのリスト
  • 主な顧客
  • 主な市場シェア分析、2022年
  • Bruker Corporation
  • Siemens Healthineers AG
  • GE Healthcare
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • VisualSonic Inc.（Fujifilm）
  • Mediso Ltd.
  • Agilent Technologies
  • MR Solutions
  • MILabs BV
  • Molecubes

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America preclinical imaging market, by region, 2018 - 2030 (USD Million)
• Table 3 North America preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 4 North America preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 5 North America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 6 U.S. preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 9 Canada preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 12 Europe preclinical imaging market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 14 Europe preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 15 Europe preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Germany preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 17 Germany preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 18 Germany preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 19 UK preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 20 UK preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 21 UK preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 22 France preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 23 France preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 24 France preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 25 Italy preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 27 Italy preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 28 Spain preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 30 Spain preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 31 Sweden preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 32 Sweden preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 33 Sweden preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 34 Denmark preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 35 Denmark preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 36 Denmark preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 37 Norway preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 38 Norway preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 39 Norway preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific preclinical imaging market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 44 China preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 45 China preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 46 China preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 47 Japan preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 48 Japan preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 49 Japan preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 50 India preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 51 India preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 52 India preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Australia preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 54 Australia preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 55 Australia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 56 South Korea preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 57 South Korea preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 58 South Korea preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 59 Thailand preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 60 Thailand preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 61 Thailand preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 62 Latin America preclinical imaging market, by region, 2018 - 2030 (USD Million)
• Table 63 Latin America preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 64 Latin America preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Brazil preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 67 Brazil preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 68 Brazil preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Mexico preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 70 Mexico preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 71 Mexico preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 72 Argentina preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 73 Argentina preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 74 Argentina preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa preclinical imaging market, by region, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 79 South Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 80 South Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 81 South Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 85 UAE preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 86 UAE preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 87 UAE preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
• Table 88 Kuwait preclinical imaging market, by product, 2018 - 2030 (USD Million)
• Table 89 Kuwait preclinical imaging market, by application, 2018 - 2030 (USD Million)
• Table 90 Kuwait preclinical imaging market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Preclinical imaging market: market outlook
• Fig. 14 Preclinical imaging market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Preclinical imaging market driver impact
• Fig. 20 Preclinical imaging market restraint impact
• Fig. 21 Preclinical imaging market strategic initiatives analysis
• Fig. 22 Preclinical imaging market: product movement analysis
• Fig. 23 Preclinical imaging market: product outlook and key takeaways
• Fig. 24 CT market estimates and forecast, 2018 - 2030
• Fig. 25 MRI market estimates and forecast, 2018 - 2030
• Fig. 26 PET/SPECT market estimates and forecast, 2018 - 2030
• Fig. 27 Multi-Modal market estimates and forecast, 2018 - 2030
• Fig. 28 Optical market estimates and forecast, 2018 - 2030
• Fig. 29 Ultrasound market estimates and forecast, 2018 - 2030
• Fig. 30 Photoacoustic market estimates and forecast, 2018 - 2030
• Fig. 31 Reagents market estimates and forecast, 2018 - 2030
• Fig. 32 Services market estimates and forecast, 2018 - 2030
• Fig. 33 Preclinical imaging market: application movement analysis
• Fig. 34 Preclinical imaging market: application outlook and key takeaways
• Fig. 35 Research and development market estimates and forecast, 2018 - 2030
• Fig. 36 Drug discovery market estimates and forecast, 2018 - 2030
• Fig. 37 Preclinical imaging market: end-use movement analysis
• Fig. 38 Preclinical imaging market: end-use outlook and key takeaways
• Fig. 39 Pharma and biotech companies market estimates and forecast, 2018 - 2030
• Fig. 40 Research institutes market estimates and forecast, 2018 - 2030
• Fig. 41 Others market estimates and forecast, 2018 - 2030
• Fig. 42 Global preclinical imaging market: regional movement analysis
• Fig. 43 Global preclinical imaging market: regional outlook and key takeaways
• Fig. 44 Global market shares and leading players
• Fig. 45 North America market share and leading players
• Fig. 46 Europe market share and leading players
• Fig. 47 Asia Pacific market share and leading players
• Fig. 48 Latin America market share and leading players
• Fig. 49 Middle East & Africa market share and leading players
• Fig. 50 North America: SWOT
• Fig. 51 Europe SWOT
• Fig. 52 Asia Pacific SWOT
• Fig. 53 Latin America SWOT
• Fig. 54 MEA SWOT
• Fig. 55 North America, by country
• Fig. 56 North America
• Fig. 57 North America market estimates and forecast, 2018 - 2030
• Fig. 58 U.S.
• Fig. 59 U.S. market estimates and forecast, 2018 - 2030
• Fig. 60 Canada
• Fig. 61 Canada market estimates and forecast, 2018 - 2030
• Fig. 62 Europe
• Fig. 63 Europe. market estimates and forecast, 2018 - 2030
• Fig. 64 UK
• Fig. 65 UK market estimates and forecast, 2018 - 2030
• Fig. 66 Germany
• Fig. 67 Germany market estimates and forecast, 2018 - 2030
• Fig. 68 France
• Fig. 69 France market estimates and forecast, 2018 - 2030
• Fig. 70 Italy
• Fig. 71 Italy market estimates and forecast, 2018 - 2030
• Fig. 72 Spain
• Fig. 73 Spain market estimates and forecast, 2018 - 2030
• Fig. 74 Sweden
• Fig. 75 Sweden market estimates and forecast, 2018 - 2030
• Fig. 76 Denmark
• Fig. 77 Denmark market estimates and forecast, 2018 - 2030
• Fig. 78 Norway
• Fig. 79 Norway market estimates and forecast, 2018 - 2030
• Fig. 80 Asia Pacific
• Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 82 China
• Fig. 83 China market estimates and forecast, 2018 - 2030
• Fig. 84 Japan
• Fig. 85 Japan market estimates and forecast, 2018 - 2030
• Fig. 86 India
• Fig. 87 India market estimates and forecast, 2018 - 2030
• Fig. 88 Australia
• Fig. 89 Australia market estimates and forecast, 2018 - 2030
• Fig. 90 South Korea
• Fig. 91 South Korea market estimates and forecast, 2018 - 2030
• Fig. 92 Thailand
• Fig. 93 Thailand market estimates and forecast, 2018 - 2030
• Fig. 94 Latin America
• Fig. 95 Latin America market estimates and forecast, 2018 - 2030
• Fig. 96 Brazil
• Fig. 97 Brazil market estimates and forecast, 2018 - 2030
• Fig. 98 Mexico
• Fig. 99 Mexico market estimates and forecast, 2018 - 2030
• Fig. 100 Argentina
• Fig. 101 Argentina market estimates and forecast, 2018 - 2030
• Fig. 102 Middle East and Africa
• Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 104 Saudi Arabia
• Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 106 South Africa
• Fig. 107 South Africa market estimates and forecast, 2018 - 2030
• Fig. 108 UAE
• Fig. 109 UAE market estimates and forecast, 2018 - 2030
• Fig. 110 Kuwait
• Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 112 Participant categorization- preclinical imaging market
• Fig. 113 Market share of key market players- preclinical imaging market

Preclinical Imaging Market Growth & Trends:

The global preclinical imaging market size is anticipated to reach USD 5.95 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 4.74% from 2023 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights:

• Based on product, the optical imaging segment held the largest revenue share of 13.6% in 2022 owing to its wide usage in small animal imaging and new drug discovery projects
• In terms of application, the research and development segment held the largest revenue share of 54.93% in 2022 owing to the technological advancements and improved healthcare infrastructure
• In terms of end-use, the pharma and biotech companies segment held the largest revenue share of 40.19% in 2022. The constant research activities and innovation of products in pharma & biotech companies have led market players to increase their product sales, driving market growth
• Based on region, North America held the largest revenue share in 2022 owing to the well-developed research infrastructure, a large number of preclinical projects, and higher adoption rates of technically advanced devices in the region can be attributed to this share
• Major players in the industry are focusing on the launch of advanced technology and features such as artificial intelligence-enabled systems

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Technological advancements
    • 3.4.1.2. Growing number of investments and funding in research and development
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Strict regulatory framework
• 3.5. Preclinical Imaging Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. CT Imaging
  • 4.1.2. MRI Imaging
  • 4.1.3. PET/SPECT Imaging
  • 4.1.4. Multi-modal Imaging
  • 4.1.5. Optical Imaging
  • 4.1.6. Ultrasound Imaging
  • 4.1.7. Photoacoustic Imaging
  • 4.1.8. Reagents
  • 4.1.9. Services
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Preclinical Imaging Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. CT imaging
    • 4.5.1.1. CT imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. MRI imaging
    • 4.5.2.1. MRI imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. PET/SPECT imaging
    • 4.5.3.1. PET/SPECT imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Multi-modal imaging
    • 4.5.4.1. Multi-modal imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.5. Optical imaging
    • 4.5.5.1. Optical imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.6. Ultrasound imaging
    • 4.5.6.1. Ultrasound imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.7. Photoacoustic imaging
    • 4.5.7.1. Photoacoustic imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.8. Reagents
    • 4.5.8.1. Reagents imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.9. Services
    • 4.5.9.1. Services market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Research and Development
  • 5.1.2. Drug Discovery
• 5.2. Application Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Preclinical Imaging Market by Application Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Research and Development
    • 5.5.1.1. Research and development market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Drug Discovery
    • 5.5.2.1. Drug discovery market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Preclinical Imaging Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Pharma and Biotech Companies
  • 6.1.2. Research Institutes
  • 6.1.3. Others
• 6.2. End-use Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Preclinical Imaging Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Pharma and Biotech Companies
    • 6.5.1.1. Pharma and biotech companies market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Research Institutes
    • 6.5.2.1. Research institutes market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Others
    • 6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2020 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2020
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East and Africa
• 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
• 7.7. North America
  • 7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.2. U.S.
    • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. Canada
    • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.8. Europe
  • 7.8.1. UK
    • 7.8.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.2. Germany
    • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.3. France
    • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.4. Italy
    • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.5. Spain
    • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.6. Sweden
    • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.7. Norway
    • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.8. Denmark
    • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.9. Asia Pacific
  • 7.9.1. Japan
    • 7.9.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.2. China
    • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.3. India
    • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.4. South Korea
    • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.5. Australia
    • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.6. Thailand
    • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.6.2.
• 7.10. Latin America
  • 7.10.1. Brazil
    • 7.10.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.2. Mexico
    • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.3. Argentina
    • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.11. MEA
  • 7.11.1. Saudi Arabia
    • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.2. South Africa
    • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.3. UAE
    • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.4. Kuwait
    • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2022
  • 8.3.4. Bruker Corporation
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Siemens Healthineers AG
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. GE Healthcare
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. TriFoil Imaging
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. PerkinElmer, Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. VisualSonic Inc. (Fujifilm)
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Mediso Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Agilent Technologies
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. MR Solutions
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. MILabs B.V.
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Molecubes
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives